Patents diary June 2020: UK Supreme Court holds Regeneron's transgenic mice patents invalid
Territorial licensing: "start at the end before you begin"
Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow
Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues
NHS can procure drugs for use outside of their approved indications if it's cheaper, court says
Everything biologic and biosimilar in-house counsel need to know about COVID-19
Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?
An exploration of patent pools, R&D and current initiatives.
2 von 6 Insights